-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price traded up 10.9% during trading on Wednesday . The company traded as high as $8.27 and last traded at $8.17. 3,458,726 shares were traded during mid-day trading, an increase of 2% from the average session volume of 3,376,665 shares. The stock had previously closed at $7.37.
Mind Medicine (MindMed) Stock Performance
The business’s 50 day simple moving average is $7.27 and its two-hundred day simple moving average is $6.92.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Further Reading
- Five stocks we like better than Mind Medicine (MindMed)
- Canada Bond Market Holiday: How to Invest and Trade
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
-inc-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}